company background image
DPH

Dechra Pharmaceuticals LSE:DPH Stock Report

Last Price

UK£26.80

Market Cap

UK£3.1b

7D

0.2%

1Y

-46.2%

Updated

06 Dec, 2022

Data

Company Financials +
DPH fundamental analysis
Snowflake Score
Valuation2/6
Future Growth3/6
Past Performance2/6
Financial Health5/6
Dividends3/6

DPH Stock Overview

Dechra Pharmaceuticals PLC develops, manufactures, regulates, markets, and sells veterinary pharmaceuticals and related products for veterinarians.

Dechra Pharmaceuticals PLC Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Dechra Pharmaceuticals
Historical stock prices
Current Share PriceUK£26.80
52 Week HighUK£53.95
52 Week LowUK£24.87
Beta0.69
1 Month Change3.08%
3 Month Change-15.72%
1 Year Change-46.16%
3 Year Change-1.76%
5 Year Change30.99%
Change since IPO1,930.30%

Recent News & Updates

Dechra Pharmaceuticals (LON:DPH) Is Increasing Its Dividend To £0.3289

Oct 06
Dechra Pharmaceuticals (LON:DPH) Is Increasing Its Dividend To £0.3289

Recent updates

Dechra Pharmaceuticals (LON:DPH) Is Increasing Its Dividend To £0.3289

Oct 06
Dechra Pharmaceuticals (LON:DPH) Is Increasing Its Dividend To £0.3289

Dechra Pharmaceuticals (LON:DPH) Is Paying Out A Larger Dividend Than Last Year

Sep 22
Dechra Pharmaceuticals (LON:DPH) Is Paying Out A Larger Dividend Than Last Year

Dechra Pharmaceuticals (LON:DPH) Will Pay A Larger Dividend Than Last Year At £0.3289

Sep 08
Dechra Pharmaceuticals (LON:DPH) Will Pay A Larger Dividend Than Last Year At £0.3289

Estimating The Intrinsic Value Of Dechra Pharmaceuticals PLC (LON:DPH)

Aug 18
Estimating The Intrinsic Value Of Dechra Pharmaceuticals PLC (LON:DPH)

Do Dechra Pharmaceuticals' (LON:DPH) Earnings Warrant Your Attention?

Aug 02
Do Dechra Pharmaceuticals' (LON:DPH) Earnings Warrant Your Attention?

These 4 Measures Indicate That Dechra Pharmaceuticals (LON:DPH) Is Using Debt Reasonably Well

Jun 10
These 4 Measures Indicate That Dechra Pharmaceuticals (LON:DPH) Is Using Debt Reasonably Well

Calculating The Fair Value Of Dechra Pharmaceuticals PLC (LON:DPH)

May 08
Calculating The Fair Value Of Dechra Pharmaceuticals PLC (LON:DPH)

Do Dechra Pharmaceuticals's (LON:DPH) Earnings Warrant Your Attention?

Apr 22
Do Dechra Pharmaceuticals's (LON:DPH) Earnings Warrant Your Attention?

Dechra Pharmaceuticals (LON:DPH) Is Increasing Its Dividend To UK£0.12

Feb 23
Dechra Pharmaceuticals (LON:DPH) Is Increasing Its Dividend To UK£0.12

Is Dechra Pharmaceuticals PLC (LON:DPH) Expensive For A Reason? A Look At Its Intrinsic Value

Jan 29
Is Dechra Pharmaceuticals PLC (LON:DPH) Expensive For A Reason? A Look At Its Intrinsic Value

Is Now The Time To Put Dechra Pharmaceuticals (LON:DPH) On Your Watchlist?

Jan 11
Is Now The Time To Put Dechra Pharmaceuticals (LON:DPH) On Your Watchlist?

Here's Why Dechra Pharmaceuticals (LON:DPH) Can Manage Its Debt Responsibly

Dec 04
Here's Why Dechra Pharmaceuticals (LON:DPH) Can Manage Its Debt Responsibly

It Looks Like Shareholders Would Probably Approve Dechra Pharmaceuticals PLC's (LON:DPH) CEO Compensation Package

Oct 15
It Looks Like Shareholders Would Probably Approve Dechra Pharmaceuticals PLC's (LON:DPH) CEO Compensation Package

Dechra Pharmaceuticals' (LON:DPH) Upcoming Dividend Will Be Larger Than Last Year's

Sep 25
Dechra Pharmaceuticals' (LON:DPH) Upcoming Dividend Will Be Larger Than Last Year's

Dechra Pharmaceuticals (LON:DPH) Will Pay A Larger Dividend Than Last Year At UK£0.29

Sep 11
Dechra Pharmaceuticals (LON:DPH) Will Pay A Larger Dividend Than Last Year At UK£0.29

With EPS Growth And More, Dechra Pharmaceuticals (LON:DPH) Is Interesting

Sep 08
With EPS Growth And More, Dechra Pharmaceuticals (LON:DPH) Is Interesting

Is Dechra Pharmaceuticals PLC (LON:DPH) Worth UK£43.4 Based On Its Intrinsic Value?

Jun 17
Is Dechra Pharmaceuticals PLC (LON:DPH) Worth UK£43.4 Based On Its Intrinsic Value?

Is Dechra Pharmaceuticals PLC (LON:DPH) A Smart Choice For Dividend Investors?

Apr 09
Is Dechra Pharmaceuticals PLC (LON:DPH) A Smart Choice For Dividend Investors?

Dechra Pharmaceuticals (LON:DPH) Has A Pretty Healthy Balance Sheet

Mar 05
Dechra Pharmaceuticals (LON:DPH) Has A Pretty Healthy Balance Sheet

Are Dechra Pharmaceuticals' (LON:DPH) Statutory Earnings A Good Reflection Of Its Earnings Potential?

Feb 17
Are Dechra Pharmaceuticals' (LON:DPH) Statutory Earnings A Good Reflection Of Its Earnings Potential?

Dechra Pharmaceuticals PLC (LON:DPH) Is Going Strong But Fundamentals Appear To Be Mixed : Is There A Clear Direction For The Stock?

Feb 02
Dechra Pharmaceuticals PLC (LON:DPH) Is Going Strong But Fundamentals Appear To Be Mixed : Is There A Clear Direction For The Stock?

Did You Participate In Any Of Dechra Pharmaceuticals' (LON:DPH) Fantastic 268% Return ?

Jan 18
Did You Participate In Any Of Dechra Pharmaceuticals' (LON:DPH) Fantastic 268% Return ?

Calculating The Fair Value Of Dechra Pharmaceuticals PLC (LON:DPH)

Jan 03
Calculating The Fair Value Of Dechra Pharmaceuticals PLC (LON:DPH)

Is Dechra Pharmaceuticals PLC (LON:DPH) A Smart Choice For Dividend Investors?

Dec 19
Is Dechra Pharmaceuticals PLC (LON:DPH) A Smart Choice For Dividend Investors?

How Is Dechra Pharmaceuticals' (LON:DPH) CEO Compensated?

Dec 06
How Is Dechra Pharmaceuticals' (LON:DPH) CEO Compensated?

Trade Alert: The CEO, MD & Executive Director Of Dechra Pharmaceuticals PLC (LON:DPH), Ian Page, Has Sold Some Shares Recently

Nov 22
Trade Alert: The CEO, MD & Executive Director Of Dechra Pharmaceuticals PLC (LON:DPH), Ian Page, Has Sold Some Shares Recently

Shareholder Returns

DPHGB PharmaceuticalsGB Market
7D0.2%1.9%1.1%
1Y-46.2%8.0%-6.6%

Return vs Industry: DPH underperformed the UK Pharmaceuticals industry which returned 8% over the past year.

Return vs Market: DPH underperformed the UK Market which returned -6.6% over the past year.

Price Volatility

Is DPH's price volatile compared to industry and market?
DPH volatility
DPH Average Weekly Movement5.2%
Pharmaceuticals Industry Average Movement5.4%
Market Average Movement5.8%
10% most volatile stocks in GB Market11.1%
10% least volatile stocks in GB Market2.9%

Stable Share Price: DPH is not significantly more volatile than the rest of UK stocks over the past 3 months, typically moving +/- 5% a week.

Volatility Over Time: DPH's weekly volatility (5%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19971,998Ian Pagehttps://www.dechra.com

Dechra Pharmaceuticals PLC develops, manufactures, regulates, markets, and sells veterinary pharmaceuticals and related products for veterinarians. It operates through three segments: European Pharmaceuticals, North American Pharmaceuticals, and Pharmaceuticals Research and Development. The company offers various endocrinology, dermatology, analgesia and anesthesia, cardiovascular, and critical care products for dogs and cats; water soluble antibiotics, poultry vaccines, and pain management for poultry, pigs, and cattle; and lameness and pain management products for horses and ponies.

Dechra Pharmaceuticals PLC Fundamentals Summary

How do Dechra Pharmaceuticals's earnings and revenue compare to its market cap?
DPH fundamental statistics
Market CapUK£3.14b
Earnings (TTM)UK£58.20m
Revenue (TTM)UK£681.80m

52.4x

P/E Ratio

4.5x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
DPH income statement (TTM)
RevenueUK£681.80m
Cost of RevenueUK£297.00m
Gross ProfitUK£384.80m
Other ExpensesUK£326.60m
EarningsUK£58.20m

Last Reported Earnings

Jun 30, 2022

Next Earnings Date

Feb 27, 2023

Earnings per share (EPS)0.51
Gross Margin56.44%
Net Profit Margin8.54%
Debt/Equity Ratio47.0%

How did DPH perform over the long term?

See historical performance and comparison

Dividends

1.7%

Current Dividend Yield

84%

Payout Ratio